Skip to content

BETA Technologies

US · BETA #2100 by market cap Listed 2025
20.26 -0.64 -3.06%
Live - 5344 symbols - heartbeat 377s ago · 2026-10-08 08:37
Pre-market 20.09 -0.86%
After-hours 20.40 +0.69%
Overnight 20.05 -1.04%
Market cap
4.74B
P/B
2.93
EPS
-4.20
Reader sentiment Are you bullish or bearish on BETA?

Anonymous reader poll. Unscientific, not investment advice.

Valuation each multiple against its own 5-year range

P/B ratio 3.03 Expensive vs history 88th percentile
5-year average 0.07 · #43 of 88 in Aerospace & Defense
P/E ratio -4.65 In line with history 49th percentile
5-year average -6.20 · forward -10.60
P/S ratio 109.06 In line with history 34th percentile
5-year average 140.62 · forward 95.59 · #88 of 91 in Aerospace & Defense

Vs. peers Aerospace & Defense

Company Market cap P/E (TTM) P/B Div yield
BETA Technologies (BETA) 4.74B -4.51 2.93 0.00%
SpaceX (SPCX) 2.21T -248.30 17.36 0.00%
GE Aerospace (GE) 315.02B 36.19 17.86 0.55%
RTX Corp (RTX) 242.95B 31.74 3.66 1.54%
Boeing (BA) 148.84B 67.74 24.43 0.00%
Lockheed Martin (LMT) 115.22B 18.41 13.14 2.73%

Other StockVane-tracked companies in the same industry.

Morningstar

★★★☆☆ Fair value15.11 Economic moatNone UncertaintyExtreme

Trading 25.4% above Morningstar's fair value estimate.

Fair value

BETA Technologies Inc is assigned a 3-star quantitative star rating, indicating our belief that this share class is a balanced choice, but prudent investors should consider looking elsewhere. The stock currently trades at a 37% premium over our quantitative fair value estimate of $15.11 per share; however, this estimate should be taken with a pinch of salt due to its extreme uncertainty rating.

The company's lack of profitability undermines our quantitative valuation. Companies with low profitability are often less resilient in recessions and are likely to generate weaker future cash flows for shareholders. For example, the firm's sales yield of 2.7% lies in the bottom 10% globally. This company's inability to generate significant sales growth without meaningful capital investment is a challenge, which contributes to our view that shares are expensive.

The company's valuation metrics are an additional cause for concern. A company's valuation metrics provide insights into the market's expectations for its future growth and profitability. The firm's enterprise value to revenue ratio of 87.3, a core component of valuation, sits in the top 10% globally. This overstates the long-term cash flow growth potential of the organization. This characteristic further promotes our unfavorable price/fair value ratio.

Economic moat

With its quantitative economic moat rating of none, we do not expect this company to materially outearn its cost of capital in the long run. Additionally, the firm's moderate financial health score suggests it is acceptably positioned against adverse economic circumstances.

By Quantitative Equity Report

Quote time 2026-10-08 08:37:52 · For reference only, not investment advice and not tailored to your situation.